Replies to post #5235 on Aurinia Pharmaceuticals Inc (AUPH)

[grandma_of_jbraika]

Stellar management team, great science, Aspreva success, stellar VOC P2 results, expertise in trial design, FDA Fast Track status, etc. I simply believe that when you add it all up, it significantly boosts their odds of success in P3.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=133929331